Evaluation of antibody response of killed and live vaccines against porcine epidemic diarrhea virus in a field study

Veterinary Quarterly

Volumn 34, Issue 4, 2014, Pages 194-200

  Paudel, S ^a   Park, J E ^a   Jang, H ^b   Hyun, B H ^c   Yang, D G ^c   Shin, H J ^a  

^a Chungnam National University   (South Korea)

^b Anygen Co   (South Korea)

^c Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

Author keywords

PEDV; pig; porcine; porcine epidemic diarrhea virus; vaccine

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INACTIVATED VACCINE; LIVE VACCINE; NUCLEOCAPSID PROTEIN; PORCINE EPIDEMIC DIARRHEA VACCINE; UNCLASSIFIED DRUG; VIRUS SPIKE PROTEIN; VIRUS ANTIBODY; VIRUS VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; COLOSTRUM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; NONHUMAN; PIGLET; PORCINE EPIDEMIC DIARRHEA; PORCINE EPIDEMIC DIARRHEA VIRUS; SOW (SWINE); SWINE; VIRUS NEUTRALIZATION; ANIMAL; BLOOD; CONTROLLED CLINICAL TRIAL; CORONAVIRUS INFECTION; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; PIG; SERODIAGNOSIS; SOUTH KOREA; SWINE DISEASE; VETERINARY; VIROLOGY;

ANIMALIA; PORCINE EPIDEMIC DIARRHEA VIRUS; SUIDAE; SUS;

ANIMALS; ANTIBODIES, VIRAL; CORONAVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INJECTIONS, INTRAMUSCULAR; NEUTRALIZATION TESTS; PORCINE EPIDEMIC DIARRHEA VIRUS; REPUBLIC OF KOREA; SWINE; SWINE DISEASES; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 84919351245     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.2014.973999     Document Type: Article

References (36)

1. Bernasconi C, Guscetti F, Utiger A, Van Reeth K, Ackermann M, Pospischil A. 1995. Experimental infection of gnotobiotic piglets with a cell culture adapted porcine epidemic diarrhoea virus: clinical, histopathological, and immunohistochemical findings. In: Schwyzer M, Ackermann M, Bertoni G, Kocherhans R, McCullogh K, Engels M, Wittek R, Zanoni R, editors. Immunobiology of viral infections. Proceedings of the Third Congress of the European Society for Veterinary Virology; 1994. France: Fondation Mercel Merieux; p. 542–546.
2. Cavanagh D, Davis PJ. 1986. Coronavirus IBV: removal of spike glycopolypeptide S1 by urea abolishes infectivity and haemagglutination but not attachment to cells. J Gen Virol. 67:1443–1448.
3. Chang SH, Bae JL, Kang TJ, Kim J, Chung GH, Lim CW, Laude H, Yang MS, Jang YS. 2002. Identification of the epitope region capable of inducing neutralizing antibodies against porcine epidemic diarrhea virus. Mol Cells. 14:295–299.
4. Chen J, Wang C, Shi H, Qiu H, Liu S, Chen X, Zhang Z, Feng L. 2010. Molecular epidemiology of porcine epidemic diarrhea virus in China. Arch Virol. 155:1471–1476.
5. Cruz DJ, Kim CJ, Shin HJ. 2006. Phage-displayed peptides having similarities with porcine epidemic diarrhea virus (PEDV) neutralizing epitopes. Virology. 354:28–34.
6. Cruz DJ, Kim CJ, Shin HJ. 2008. The GPRLQPY motif located at the carboxy-terminal of the spike protein induces antibodies that neutralize porcine epidemic diarrhea virus. Virus Res. 132:192–196.
7. De Arriba ML, Carvajal A, Lanza I, Rubio P, Blanchard PC. 1995. Development of an ELISA for the detection for antibody isotypes against porcine epidemic diarrhoea virus (PEDV) in sow's milk. In: Schwyzer M, Ackermann M, Bertoni G, Kocherhans R, McCullogh K, Engels M, Wittek R, Zanoni R, editors. Immunobiology of viral infections. France: Fondation Mercel Merieux Proceedings of the Third Congress of the European Society for Veterinary Virology; 1994. France: Fondation Mercel Merieux; p. 222–225.
8. De Arriba ML, Carvajal A, Pozo J, Rubio P. 2002a. Lympho-proliferative responses and protection in conventional piglets inoculated orally with virulent or attenuated porcine epidemic diarrhoea virus. J Virol Methods. 105:37–47.
9. De Arriba ML, Carvajal A, Pozo J, Rubio P. 2002b. Mucosal and systemic isotype-specific antibody responses and protection in conventional pigs exposed to virulent or attenuated porcine epidemic diarrhoea virus. Vet Immunol Immunopathol. 85:85–97.
10. De Arriba ML, Carvajal A, Pozo J, Rubio P. 2002c. Isotype-specific antibody-secreting cells in systemic and mucosal associated lymphoid tissues and antibody responses in serum of conventional pigs inoculated with PEDV. Vet Immunol Immunopathol. 84:1–16.
11. Debouck P, Pensaert M. 1980. Experimental infection of pigs with a new porcine enteric coronavirus, CV 777. Am J Vet Res. 41:219–223.
12. Duarte M, Tobler K, Bridgen A, Rasschaert D, Ackermann M. 1994. Sequence analysis of the porcine epidemic diarrhea virus genome between the nucleocapsid and spike protein genes reveals a polymorphic ORF. Virology. 198:466–476.
13. Hofmann M, Wyler R. 1988. Propagation of the virus of porcine epidemic diarrhea in cell culture. J Clin Microbiol. 26:2235–2239.
14. Hou XL, Yu LY, Liu J, Wang GH. 2007a. Surface-displayed porcine epidemic diarrhea viral (PEDV) antigens on lactic acid bacteria. Vaccine. 26:24–31.
15. Hou XL, Yu LY, Liu J. 2007b. Development and evaluation of enzyme-linked immunosorbent assay based on recombinant nucleocapsid protein for detection of porcine epidemic diarrhea (PEDV) antibodies. Vet Microbiol. 123:86–92.
16. Kang TJ, Seo JE, Kim DH, Kim TG, Jang YS, Yang MS. 2005. Cloning and sequence analysis of the Korean strain of spike gene of porcine epidemic diarrhea virus and expression of its neutralizing epitope in plants. Protein Expr Purif. 41:378–383.
17. Kusanagi K, Kuwahara H, Katoh T, Nunoya T, Ishikawa Y, Samejima T, Tajima M. 1992. Isolation and serial propagation of porcine epidemic diarrhea virus in cell cultures and partial characterization of the isolate. J Vet Med Sci. 54:313–318.
18. Kweon CH, Kwon BJ, Jung TS, Kee YJ, Hur DH, Hwang EK, Rhee JC, An SH. 1993. Isolation of porcine epidemic diarrhea virus (PEDV) in Korea. Korean J Vet Res. 33:249–254.
19. Noda M, Yamashita H, Koide F, Kado K, Omori T, Asagi M, Inaba Y. 1987. Hemagglutination with transmissible gastroenteritis virus. Arch Virol. 96:109–115.
20. Offit PA, Clark HF. 1985. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J Virol. 54:8–64.
21. Park SJ, Kim HK, Song DS, Moon HJ, Park BK. 2011. Molecular characterization and phylogenetic analysis of porcine epidemic diarrhea virus (PEDV) field isolates in Korea. Arch Virol. 156:577–585.
22. Pensaert MB. 1999. Porcine epidemic diarrhea. In: Straw BE, D’Allaire S, Mengeling WL, Taylor DI, editors. Diseases of swine. Ames (IA): Iowa State University Press; p. 179–185.
23. Pensaert MB, de Bouck P. 1978. A new coronavirus-like particle associated with diarrhea in swine. Arch Virol. 58:243–247.
24. Pensaert MB, de Bouck P, Reynolds DJ. 1981. An immunoelectron microscopic and immunofluorescent study on the antigenic relationship between the coronavirus-like agent, CV 777, and several coronaviruses. Arch Virol. 68:45–52.
25. Penseart MB, Yeo SG. 2006. Porcine epidemic diarrhea. In: Straw BE, Zimmerman JJ, D’Allaire S, Taylor JD, editors. Diseases of swine. Ames (IA): Iowa State University Press; p. 367–372.
26. Pritchard GC, Paton DJ, Wibberley G, Ibata G. 1999. Transmissible gastroenteritis and porcine epidemic diarrhoea in Britain. Vet Rec. 144:616–618.
27. Rodak L, Valicek L, Smid B, Nevorankova Z. 1999. Detection of porcine epidemic diarrhoea virus by a monoclonal antibody immunoperoxidase test. Vet Med-Czech. 44:165–170.
28. Saif LJ, Bohl EH, Gupta RK. 1972. Isolation of porcine immunoglobulins and determination of the immunoglobulin classes of transmissible gastroenteritis viral antibodies. Infect Immun. 6:600–609.
29. Sharpee RL, Mebus CA, Bass EP. 1976. Neonatal calf diarrhea coronavirus. Am J Vet Res. 37:1031–1041.
30. Stevenson GW, Hoang H, Schwartz KJ, Burrough ER, Sun D, Madson D, Cooper VL, Pillatzki A, Gauger P, Schmitt BJ, Koster LG, Killian ML, Yoon KJ. 2013. Emergence of porcine epidemic diarrhea virus in the United States: clinical signs, lesions, and viral genomic sequences. J Vet Diagn Invest. 25:649–654.
31. Talbot, PJ. 1989. Hemagglutination by murine hepatitis viruses. Absence of detectable activity in strains 3, A59, and S grown on DBT cells. Intervirology. 30:117–120.
32. To TL, Ward LA, Yuan L, Saif LJ. 1998. Serum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J Gen Virol. 79:2661–2672.
33. Usami Y, Yamaguchi O, Kumanomido K, Matsumura Y. 1998. Antibody response of pregnant sows to porcine epidemic diarrhea virus live vaccine and maternally-derived antibodies of the piglets. J Jpn Vet Med Assoc. 51:652–655.
34. Van Cott JL, Brim TA, Lunney JK, Saif LJ. 1994. Contribution of antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge. J Immunol. 152:3.980–3.990.
35. Yuan L, Kang SY, Ward LA, To TL, Saif LJ. 1998. Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus. J Virol. 72:330–338.
36. Yuan L, Ward LA, Rosen BI, To TL, Saif LJ. 1996. Systemic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J Virol. 70:3.075–3.083.